Organogenesis Holdings Inc.
ORGO
$2.57
-$0.02-0.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4,201.05% | 113.62% | 50.25% | -373.17% | -82.59% |
| Total Depreciation and Amortization | 9.22% | 8.29% | 9.63% | 12.48% | 10.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.97% | -23.81% | -26.69% | 64.43% | 57.64% |
| Change in Net Operating Assets | -170.78% | -113.33% | -184.89% | -81.46% | -170.51% |
| Cash from Operations | -172.56% | -379.38% | -251.32% | -82.83% | -54.04% |
| Capital Expenditure | -41.06% | -28.66% | 1.57% | 39.89% | 58.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -41.06% | -28.66% | 1.57% | 39.89% | 58.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.27% | -833.54% | -889.57% | -1,022.50% | -1,207.64% |
| Issuance of Common Stock | -87.42% | 554.84% | 503.87% | 503.87% | 124,700.00% |
| Repurchase of Common Stock | 92.93% | -2,223.59% | -2,221.45% | -2,266.32% | -7,904.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -162.81% | 370.87% | 492.42% | 509.90% | 602.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.46% | -683.64% | -1,827.76% | 30,807.25% | 2,935.59% |